Abiopharma

🔍 Thomas Amiee Lynn (Director)

Company: CAVA GROUP, INC. (CAVA)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 1,821 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,821.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects a grant of restricted stock units ("RSUs"), which vest in full on the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.
• F2: Includes unvested RSUs.